Document ID: chunk:federal_register_of_legislation:F2024C01228:reg:103
Version: federal_register_of_legislation:F2024C01228
Segment Type: reg
Provision Reference: reg 103
Character Range: 43513–44887

103   Vaccine                                                                                                                                                                                                                                                                                ActHib or Hiberix  Refrigerated lyophilised preparation for injection (0.5mL) with separate diluent  Purified Hib capsular polysaccharide conjugated to tetanus toxoid — 10 µg                                                                                                                                                                                                                                                                                      1 dose (booster)
      Haemophilus influenzae type b (Hib) (monovalent PRP‑T)

      Circumstances
      Vaccine may be provided to:
       (a) a child who is about 18 months old; or
       (b) a person who is at least 5 years old and who has congenital or acquired asplenia (e.g. splenectomy) or hyposplenia and did not receive childhood vaccinations; or
       (c) a person who is undergoing treatment, or will commence treatment, with Empavali (pegcetacoplan) for the treatment of adults with paroxysmal nocturnal haemoglobinuria who have an inadequate clinical response or are intolerant to treatment with eculizumab or ravulizumab.